rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
5B
|
pubmed:dateCreated |
2007-11-1
|
pubmed:abstractText |
Caffeine, which has a DNA-repair inhibiting effect, enhances the cytocidal effects of anticancer drugs and radiation. The present study was performed to assess the efficacy of caffeine-potentiated chemotherapy for high-grade soft tissue sarcoma (STS).
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:issn |
0250-7005
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:volume |
27
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
3489-95
|
pubmed:dateRevised |
2010-11-18
|
pubmed:meshHeading |
pubmed-meshheading:17972506-Adolescent,
pubmed-meshheading:17972506-Adult,
pubmed-meshheading:17972506-Aged,
pubmed-meshheading:17972506-Antineoplastic Combined Chemotherapy Protocols,
pubmed-meshheading:17972506-Caffeine,
pubmed-meshheading:17972506-Child,
pubmed-meshheading:17972506-Disease-Free Survival,
pubmed-meshheading:17972506-Drug Synergism,
pubmed-meshheading:17972506-Female,
pubmed-meshheading:17972506-Humans,
pubmed-meshheading:17972506-Kaplan-Meier Estimate,
pubmed-meshheading:17972506-Magnetic Resonance Imaging,
pubmed-meshheading:17972506-Male,
pubmed-meshheading:17972506-Middle Aged,
pubmed-meshheading:17972506-Neoplasm Staging,
pubmed-meshheading:17972506-Preoperative Care,
pubmed-meshheading:17972506-Sarcoma,
pubmed-meshheading:17972506-Time Factors,
pubmed-meshheading:17972506-Treatment Outcome
|
pubmed:articleTitle |
Caffeine-potentiated chemotherapy for patients with high-grade soft tissue sarcoma: long-term clinical outcome.
|
pubmed:affiliation |
Department of Orthopaedic Surgery, Kanazawa University Graduate School of Medical Science, Kanazawa, Japan.
|
pubmed:publicationType |
Journal Article,
Clinical Trial
|